Blog

CRISPR genome editing and immunotherapy – the early adopter – Cancer Research UK (blog)


Cancer Research UK (blog)

CRISPR genome editing and immunotherapy – the early adopter
Cancer Research UK (blog)
But among that speculation, one area of medicine has been quick to pick up the technology and is now leading the way in early clinical trials. In this second post in our series taking a closer look at CRISPR, we explore its potential for new

and more »

2017-04-21 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.